logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Ariad Pharmaceuticals, Inc.


USPTO Granted Patents = 69



Trademarks = 6

Forward Citations = 613

Loading Chart...
Loading Chart...

75 inventors (with patents filed for the assignee):

goldMedal William C Shakespeare (34 out of 36 patents)

silverMedal Yihan Wang (33 out of 36 patents)

bronzeMedal David C Dalgarno (24 out of 25 patents)

4.  Tomi K Sawyer (22 out of 35 patents)

5.  Xiaotian Zhu (22 out of 33 patents)

6.  Wei-Sheng Huang (21 out of 22 patents)

7.  Chester A Metcalf, Iii (20 out of 34 patents)

8.  Rajeswari Sundaramoorthi (19 out of 19 patents)

9.  Leonard W Rozamus (15 out of 23 patents)

10.  Jiwei Qi (14 out of 14 patents)

11.  R Mathew Thomas (13 out of 14 patents)

12.  Feng Li (11 out of 14 patents)

13.  Regine Bohacek (11 out of 12 patents)

14.  Dong Zou (10 out of 15 patents)

15.  Pradeep Kumar Sharma (10 out of 15 patents)


Core Competencies:
c-Kit Inhibitors
HPK1 Inhibitors
Kinase Inhibition
Cell Proliferation
Aminothiazole Compounds
Crystalline Forms
Acetylenic Heteroaryl Compounds
Phosphorus Derivatives
Multimerizing Agents
Oral Formulations
Cancer Treatment
Heterocycles

69 patents:

1. 11753404 - Aminothiazole compounds as c-Kit inhibitors (2023-09-12),
2. 11384086 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1- yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2022-07-12),
3. 11279705 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2022-03-22),
4. 11192897 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2021-12-07),
5. 11192896 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2021-12-07),
6. 11192895 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2021-12-07),
7. 11180482 - Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitors (2021-11-23),
8. 11117883 - Benzimidazole compounds as c-Kit inhibitors (2021-09-14),
9. 11001580 - Aminothiazole compounds as c-Kit inhibitors (2021-05-11),
10. 10934317 - Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine (2021-03-02),
11. 10662197 - Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2020-05-26),
12. 10385078 - Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine (2019-08-20),
13. 10227342 - Heteroaryl compounds for kinase inhibition (2019-03-12),
14. 10125136 - Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2018-11-13),
15. 9834571 - Compounds for inhibiting cell proliferation in EGFR-driven cancers (2017-12-05),
ARIAD Pharmaceuticals, Inc. is a global biopharmaceutical company focused on discovering, developing, and commercializing precision therapies for patients with rare cancers. They are committed to transforming the lives of patients through innovative research and development, with a focus on targeted therapies and personalized medicine. ARIAD Pharmaceuticals believes in advancing breakthrough treatments that can make a difference in the lives of patients and provide hope for a better future.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
69 Patents

#35 in Cambridge, MA

#285 in Massachusetts

#5,093 in US

#10,350 in the World

...
Cambridge, MA, United States of America

Ariad Pharmaceuticals, Inc.

Forward Citations = 613

75 inventors:

goldMedal William C Shakespeare (34 out of 36 patents)

silverMedal Yihan Wang (33 out of 36 patents)

bronzeMedal David C Dalgarno (24 out of 25 patents)

4.  Tomi K Sawyer (22 out of 35 patents)

5.  Xiaotian Zhu (22 out of 33 patents)

Please report any incorrect information to support@idiyas.com
Loading…